Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
85
datasets available to search
ShareScore release 0.9.0
Dataset results
85 results for “golimumab”
Golimumab Utilization and Impact on Ulcerative Colitis (MK-8259-032)
ClinicalTrials.gov study NCT02092285. IPD Sharing: YES. Countries: 1. Publications: 1.
A Study of Efficacy and Safety of Combination Therapy With Guselkumab and Golimumab in Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03662542. IPD Sharing: Not stated. Countries: 9. Publications: 2.
A Safety and Effectiveness Study of Golimumab in Japanese Patients With Moderately to Severely Active Ulcerative Colitis.
ClinicalTrials.gov study NCT01863771. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study of the Safety and Efficacy of Golimumab in Subjects With Rheumatoid Arthritis That Are Methotrexate-naive
ClinicalTrials.gov study NCT00264537. IPD Sharing: Not stated. Countries: 21. Publications: 5.
A Study to Assess the Efficacy and Safety of Golimumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis
ClinicalTrials.gov study NCT03596645. IPD Sharing: Not stated. Countries: 11. Publications: 1.
An Effectiveness and Safety Study of Intravenous Golimumab in Patients With Active Rheumatoid Arthritis Despite Treatment With Methotrexate Therapy
ClinicalTrials.gov study NCT00973479. IPD Sharing: Not stated. Countries: 13. Publications: 7.
A Study of the Safety and Efficacy of Golimumab (CNTO 148) in Subjects With Active Rheumatoid Arthritis Previously Treated With Biologic Anti-TNFa Agent(s)
ClinicalTrials.gov study NCT00299546. IPD Sharing: Not stated. Countries: 10. Publications: 4.
Preference for a Prefilled Syringe or Smartject™ Device for Delivering Golimumab in Participants Suffering From Moderate-to-severe Ulcerative Colitis (MK-8259-027)
ClinicalTrials.gov study NCT02155335. IPD Sharing: YES. Countries: 0. Publications: 1.
Subcutaneous Golimumab (GLM) Plus DMARDs for Rheumatoid Arthritis, Followed by Intravenous/Subcutaneous GLM Strategy (P06129 AM2)
ClinicalTrials.gov study NCT00975130. IPD Sharing: YES. Countries: 0. Publications: 4.
Targeting Beta Cell Dysfunction With Liraglutide or Golimumab in Longstanding T1D
ClinicalTrials.gov study NCT03632759. IPD Sharing: UNDECIDED. Countries: 1. Publications: 1.
Exploration of TNF-alpha Blockade With Golimumab in the Induction of Clinical Remission in Patients With Early Peripheral Spondyloarthritis (SpA) According to ASAS-criteria
ClinicalTrials.gov study NCT01426815. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Comparison of Two Different Golimumab Dosing Regimens for Ulcerative Colitis
ClinicalTrials.gov study NCT04156984. IPD Sharing: NO. Countries: 1. Publications: 1.
Initial Treatment With Golimumab in Early PsA
ClinicalTrials.gov study NCT01871649. IPD Sharing: Not stated. Countries: 1. Publications: 2.
The Incidence of Extra-Articular Manifestations in Participants With Ankylosing Spondylitis Treated With Golimumab (MK-8259-012)
ClinicalTrials.gov study NCT01668004. IPD Sharing: YES. Countries: 0. Publications: 1.
A Study to Evaluate the Accuracy of a Subset of the Length-109 Probe Set Panel (a Genetic Test) in Predicting Response to Golimumab in Participants With Moderately to Severely Active Ulcerative Coliti
ClinicalTrials.gov study NCT01988961. IPD Sharing: Not stated. Countries: 12. Publications: 2.
Golimumab Dried Blood Spot Analysis
ClinicalTrials.gov study NCT02910375. IPD Sharing: NO. Countries: 1. Publications: 1.
A Study to Investigate the Use of Golimumab (Simponi®) in Participants With Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis (P06554)
ClinicalTrials.gov study NCT01313858. IPD Sharing: Not stated. Countries: 0. Publications: 3.
A Pharmacokinetic (PK) and Pharmacodynamic (PD) Study of Golimumab in Patients With Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT01362153. IPD Sharing: Not stated. Countries: 1. Publications: 2.
Correlation of Soluble Suppression of Tumorigenicity 2 (ST2) With Golimumab (MK-8259) Response in Participants With Ulcerative Colitis (UC) (MK-8529-022).
ClinicalTrials.gov study NCT02318667. IPD Sharing: YES. Countries: 0. Publications: 2.
A Safety and Efficacy Study of Golimumab (CNTO148) in Patients With Active Rheumatoid Arthritis (RA)
ClinicalTrials.gov study NCT00771251. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.